Prohost Letter #403 Part 2

Prohost Letter #403 Part 2

Prohost Letter #403 Part 2 Continued From Wednesday Instead of continuing yesterday article about Agenus, we …
Prohost Letter #403 Part 1

Prohost Letter #403 Part 1

ProhostLetter #403 Part 1 On December 8, 2016 under News & Comments Prohost commented on President …
Prohost Letter #402

Prohost Letter #402

Prohost Letter #402 Antisense Proof of Concept and Feasibility EYE ON INVIVA (INVA) Sales of The …
It Is All About Array Biopharma

It Is All About Array Biopharma

Prohost Biotech On   ARRAY PHARMACEUTICALS Under the title “Halozyme has Good News and Array Too”, we …
Prohost Letter #401

Prohost Letter #401

Prohost Letter #401 SYNOPSIS PART 1 In this Letter CONTENTS Duchenne Muscular Dystrophy (DMD) FDA Compassionate …
Prohost Letter #400

Prohost Letter #400

Prohost Letter #400 NEAR-­TERM INVESTING The Prohost Letter #399 Part 3 has Promised to Des